Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-10 · accession 0001415889-24-003525 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-10 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | +2,502 | 11.6K | +28% | $0 |
| D | 2024-02-13 | 2024-02-10 | HALO | LaBrosse Nicole | SVP, CFO | F - Tax | $35.49 | -1,477 | 10.1K | -13% | -$52.4K |
| D | 2024-02-13 | 2024-02-10 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | -2,502 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-10 | M | A | 2,502 | $0.00 | 11,568 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-10 | F | D | 1,477 | $35.49 | 10,091 | D | — | — | (F1) The reported disposition of 1,477 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. |
| 3 | Derivative | Restricted Stock Units | 2024-02-10 | M | D | 2,502 | $0.00 | 0 | D | $0.00 · — to — | 2,502 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |